Jingjing Wu
-
- Hepatitis C virus research 5
-
- Chronic Myeloid Leukemia Treatments 5
-
- Chronic Lymphocytic Leukemia Research 4
-
- Liver Disease Diagnosis and Treatment 4
-
- Esophageal Cancer Research and Treatment 3
-
- Systemic Lupus Erythematosus Research 3
-
- Cancer-related gene regulation 3
- RNA modifications and cancer 3
- Cited by
- Cancer ResearchImmunologyHepatology
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jingjing Wu
47 papers receiving 757 citations
Peers
Comparison fields: 5 of 114
- Cancer Research 130
- Immunology 139
- Hepatology 46
- Nephrology 37
- Biological Psychiatry 13
Countries citing papers authored by Jingjing Wu
This map shows the geographic impact of Jingjing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Wu more than expected).
Fields of papers citing papers by Jingjing Wu
This network shows the impact of papers produced by Jingjing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Wu. The network helps show where Jingjing Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingjing Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 65 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 49 | |
| 13 | 2020 | 39 | |
| 14 | 2019 | 1 | |
| 15 | 2018 | 3 | |
| 16 | 2018 | 20 | |
| 17 | 2016 | 8 | |
| 18 | 2015 | 11 | |
| 19 | 2014 | 50 | |
| 20 | 2012 | 37 |
About Jingjing Wu
Jingjing Wu is a scholar working on Health Informatics, Hepatology and Genetics, having authored 52 papers that have together received 763 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (5 papers), Hepatitis C virus research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Esophageal Cancer Research and Treatment (3 papers), Systemic Lupus Erythematosus Research (3 papers), Cancer-related gene regulation (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (130 citations), Immunology (139 citations) and Hepatology (46 citations). Jingjing Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bin Wei, Wenjie Guo, Qiang Xu, Yanhong Gu, Wen Liu, Meijuan Zou, Lian‐Wen Qi, Xiaomin Cai, Wei Zhu and Lingyan Xu. Their work appears in journals such as Cancer Research, Scientific Reports and Optics Express.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.